抗意义抑制的RNA聚合酶αClostridioides difficile的子单元
Rusha Pal1, Mohamed N Seleem1,2
1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
核酸 (PNA) 提供了一种新的方法,通过向必不可少的rpoA基因来对抗Clostridioides difficile感染. 这种方法有效地抑制了病原体的生长,并减少了毒性,而不会伤害有益的肠道细菌.
科学领域:
- 微生物学 微生物学
- 抗微生物治疗药物 抗微生物治疗药物
- 分子生物学分子生物学
背景情况:
- 艰难菌感染 (CDI) 是与抗生素相关的腹的一个重要原因.
- 目前针对CDI的抗生素疗法可以破坏肠道微生物群的平衡,导致复发性感染.
- 需要新的治疗策略来解决现有治疗方法的局限性.
研究的目的:
- 研究核酸 (PNA) 作为针对C. difficile的向治疗剂的潜力.
- 评估一种针对C. difficile中的RNA聚合酶α子单元 (rpoA) 基因的新型PNA构造的疗效.
主要方法:
- 一个针对C. difficile rpoA基因的PNA结构的设计和合成.
- 对临床C. difficile分离物的PNA抑制和杀菌活性的评估.
- 评估PNA对毒性因子 (tcdA,tcdB) 和分泌基因 (spoOA) 表达的影响.
- 在不同的pH条件下和对高致病原体注射剂的PNA疗效的测试.
- 对有益的肠道微生物群的PNA特异性的评估.
主要成果:
- 设计的抗rpoA PNA结构显示出对临床C. difficile分离物的抑制活性,最小的抑制度在4至8μM之间.
- 该PNA表现出杀菌活性,并抑制了关键毒性基因 (tcdA,tcdB) 和分泌基因 (spoOA) 的表达.
- 在不同的pH值和高病原体负载中,PNA的有效性保持一致.
- PNA结合物对C. difficile具有很高的特异性,没有抑制有益的肠道微生物群.
结论:
- rpoA基因代表了对C. difficile感染的狭窄谱治疗有前途的治疗标.
- 基于PNA的rpoA抑制提供了一种新的策略,通过准基本基因表达来对抗CDI.
- 这种方法有可能解除毒性因素并防止复发,而不会破坏肠道微生物群.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
09:53A Purification and In Vitro Activity Assay for a pppGpp Synthetase from Clostridium difficile
Published on: November 3, 2018
相关概念视频
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
